Neurocrine Biosciences Inc

Candriam S.C.A. NBIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

293,096

Value ($000)

41,572

Weight

0.2%

2019 Q3 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	41,572	0.2%	293,096	12/31/2025
2025 Q3	11/6/2025	40,380	0.2%	287,645	9/30/2025
2025 Q2	8/8/2025	37,526	0.2%	298,551	6/30/2025
2025 Q1	5/14/2025	36,591	0.2%	330,840	3/31/2025
2024 Q4	2/7/2025	41,492	0.2%	303,972	12/31/2024
2024 Q3	11/13/2024	55,677	0.3%	483,241	9/30/2024
2024 Q2	8/5/2024	64,078	0.4%	465,467	6/30/2024
2024 Q1	5/6/2024	43,539	0.3%	315,684	3/31/2024
2023 Q4	2/14/2024	48,740	0.3%	369,899	12/31/2023
2023 Q3	11/13/2023	42,439	0.3%	377,238	9/30/2023
2023 Q2	8/8/2023	41,531	0.3%	440,416	6/30/2023
2023 Q1	5/12/2023	38,867	0.3%	417,180	3/31/2023
2022 Q4	2/13/2023	32,148	0.2%	269,172	12/31/2022
2022 Q3	11/10/2022	28,835	0.2%	271,481	9/30/2022
2022 Q2	8/3/2022	32,257	0.3%	330,929	6/30/2022
2022 Q1	5/13/2022	28,143	0.2%	300,207	3/31/2022
2021 Q4	2/10/2022	26,395	0.2%	309,913	12/31/2021
2021 Q3	11/9/2021	7,818	0.1%	81,513	9/30/2021
2021 Q2	7/20/2021	7,931	0.1%	81,493	6/30/2021
2021 Q1	4/29/2021	15,945	0.1%	162,469	3/31/2021
2020 Q4	1/22/2021	16,601	0.1%	162,469	12/31/2020
2020 Q3	10/19/2020	15,027	0.1%	156,282	9/30/2020
2020 Q2	7/23/2020	19,067	0.2%	156,282	6/30/2020
2020 Q1	5/26/2020	19,625	0.2%	186,766	3/31/2020
2019 Q4	2/5/2020	20,075	0.2%	186,766	12/31/2019
2019 Q3	2/5/2020	18,443	0.2%	204,669	9/30/2019